Eczema itches because of a chain reaction involving a damaged skin barrier, an overactive immune system, and nerves that become increasingly sensitive over time. Unlike a mosquito bite or poison ivy, where histamine drives most of the itch, eczema itch runs primarily through non-histamine pathways. That’s why popping an antihistamine often does little to help.
A Broken Skin Barrier Lets Irritants In
Healthy skin works like a sealed wall, keeping moisture in and allergens, bacteria, and chemical irritants out. A protein called filaggrin is critical to this barrier. It helps form and hydrate the outermost layer of skin, and as it breaks down naturally, its components hold moisture in place. Up to half of people with moderate to severe eczema carry mutations that reduce filaggrin production or eliminate it entirely.
Without enough filaggrin, the skin develops microscopic cracks. Water escapes (which is why eczema skin feels dry and flaky), and allergens that would normally sit harmlessly on the surface slip through into deeper layers. Once foreign material crosses that barrier, immune cells detect it and launch an inflammatory response. That inflammation is what starts the itch.
Immune Signals That Fire Up Itch Nerves
The immune cells recruited to inflamed skin release a flood of signaling molecules, and one of the most important for itch is a protein called IL-31. It’s produced mainly by a type of immune cell that dominates in allergic conditions. IL-31 doesn’t just cause general inflammation. It binds directly to receptors on sensory nerve fibers in the skin, essentially telling those nerves to fire an itch signal to the brain. The receptors for IL-31 are most heavily concentrated on the nerve clusters that relay sensation from the skin to the spinal cord, which is why the itch signal is so strong and specific.
Other inflammatory molecules pile on. Skin cells under stress release proteins called alarmins (IL-25, IL-33, and TSLP) that amplify allergic-type inflammation, recruiting even more immune cells and creating a self-reinforcing loop. The result is itch that builds rather than fades.
Nerves Grow Denser and More Sensitive
In healthy skin, nerve fibers extend into the upper layers at a normal density, kept in check by a balance of signals: some encourage nerve growth, others push nerve endings back. In eczema, that balance breaks. Levels of a nerve-repelling signal called semaphorin 3A drop, while nerve growth factor rises. The practical effect is that more nerve endings sprout into the upper skin layers, making the same patch of skin far more sensitive to any itch trigger.
This isn’t just about more nerves picking up more signals. The nerves themselves become hypersensitized. People with eczema show significantly greater itch responses to non-histamine itch triggers both inside and outside their visible lesions, while their response to pure histamine is no different from people without eczema. In other words, the nervous system recalibrates. Stimuli that wouldn’t normally register as itchy (light touch, fabric, warmth) start triggering itch, a phenomenon called alloknesis.
Bacteria on the Skin Make It Worse
Most people with eczema have unusually high levels of Staphylococcus aureus bacteria colonizing their skin. These bacteria aren’t just passive bystanders. S. aureus produces a specific enzyme called V8 protease that directly activates sensory nerve fibers. It does this by cleaving a receptor (PAR1) sitting on the surface of itch-sensing neurons, essentially flipping a switch that tells those neurons to fire.
In lab studies, about 27% of human sensory neurons responded to V8 protease, and nearly all of those neurons were the same pain-and-itch-sensing type that responds to capsaicin (the compound that makes chili peppers burn). Blocking the PAR1 receptor significantly reduced both itching and the skin damage that follows from scratching. This bacterial contribution helps explain why eczema flares often coincide with skin infections, and why keeping bacterial overgrowth in check can reduce itch intensity.
Why Scratching Makes Everything Worse
Scratching feels like it should relieve the itch, and for a moment it does, because the mechanical sensation temporarily overrides the itch signal in the spinal cord. But the damage from scratching triggers its own cascade. Skin cells respond to mechanical injury by releasing proteases, antimicrobial peptides, and inflammatory cytokines. One family of proteases, the kallikreins, becomes dysregulated in eczema skin and promotes further barrier breakdown and inflammation. Scratched skin also releases molecules that activate nearby immune cells through pathways that directly promote more scratching behavior.
This is the itch-scratch cycle: itch triggers scratching, scratching damages the barrier, barrier damage triggers inflammation, and inflammation generates more itch signals. Each pass through the loop can recruit new immune cells, deepen nerve sensitization, and widen the area of affected skin. Breaking this cycle is one of the central goals of eczema treatment.
Why It Gets Worse at Night
If your eczema itch feels most unbearable at bedtime, there are real physiological reasons for that. Several body processes shift at night in ways that amplify itch.
- Cortisol drops. Your body’s natural anti-inflammatory hormone hits its lowest point in the evening and overnight. With less cortisol circulating, inflammatory responses face less opposition, and itch-promoting cytokines like IL-2 increase (partly because cortisol normally suppresses IL-2 production).
- Skin temperature rises. During non-REM sleep, your body sheds core heat through the skin by dilating blood vessels near the surface. The resulting increase in skin temperature and blood flow can intensify itch.
- Fewer distractions. During the day, your brain filters and suppresses low-level itch signals while you focus on tasks. At night, with fewer competing inputs, those signals reach conscious awareness more easily.
Why Antihistamines Don’t Help Much
Most over-the-counter itch remedies target histamine, the molecule behind hives and mosquito-bite itch. But research consistently shows that eczema itch is dominated by non-histamine pathways. When researchers tested itch responses in people with eczema, they found dramatically increased sensitivity to non-histamine itch triggers but no significant difference in histamine-driven itch compared to healthy controls. The primary itch circuits in eczema run through IL-31 signaling, bacterial proteases activating PAR1, and sensitized nerve fibers responding to mechanical stimulation.
This is why sedating antihistamines sometimes seem to help at night: they make you drowsy enough to sleep through the itch, but they aren’t actually reducing the itch signal itself. Newer treatments that target IL-31 signaling or the broader type-2 inflammatory response tend to be far more effective at reducing eczema itch at its source, because they interrupt the pathways that are actually driving it.